$300 Million is the total value of BRIDGER MANAGEMENT, LLC's 29 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CZR | CAESARS ENTERTAINMENT INC NE | $23,676,839 | +4.4% | 464,525 | 0.0% | 7.88% | -6.8% | |
| CHTR | CHARTER COMMUNICATIONS INC Ncl a | $18,703,909 | +2.7% | 50,913 | 0.0% | 6.23% | -8.3% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12,393,420 | -10.9% | 142,979 | 0.0% | 4.13% | -20.4% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $11,295,000 | -14.9% | 1,500,000 | 0.0% | 3.76% | -24.1% | |
| QTRX | QUANTERIX CORP | $3,492,995 | +100.1% | 154,900 | 0.0% | 1.16% | +78.6% | |
| WILLIAMS ROWLAND ACQUISITION | $3,079,890 | +1.2% | 297,000 | 0.0% | 1.03% | -9.7% | ||
| RETA | REATA PHARMACEUTICALS INCcl a | $2,528,608 | +12.1% | 24,800 | 0.0% | 0.84% | +0.1% | |
| GOOGL | ALPHABET INCcap stk cl a | $1,663,830 | +15.4% | 13,900 | 0.0% | 0.55% | +3.0% | |
| SURROZEN INC | $33,934 | -8.6% | 61,699 | 0.0% | 0.01% | -21.4% | ||
| SURROZEN INC*w exp 08/01/203 | $25,760 | -9.5% | 466,666 | 0.0% | 0.01% | -18.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.